X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB MERCK LTD UNICHEM LAB/
MERCK LTD
 
P/E (TTM) x 29.8 33.5 89.0% View Chart
P/BV x 3.1 3.8 83.7% View Chart
Dividend Yield % 0.6 0.8 80.2%  

Financials

 UNICHEM LAB   MERCK LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
MERCK LTD
Dec-16
UNICHEM LAB/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3341,060 31.5%   
Low Rs174623 27.9%   
Sales per share (Unadj.) Rs146.9632.4 23.2%  
Earnings per share (Unadj.) Rs11.945.7 26.0%  
Cash flow per share (Unadj.) Rs16.262.3 26.0%  
Dividends per share (Unadj.) Rs2.0011.00 18.2%  
Dividend yield (eoy) %0.81.3 60.2%  
Book value per share (Unadj.) Rs105.1388.8 27.0%  
Shares outstanding (eoy) m90.8416.60 547.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.3 129.9%   
Avg P/E ratio x21.418.4 116.0%  
P/CF ratio (eoy) x15.713.5 116.2%  
Price / Book Value ratio x2.42.2 111.7%  
Dividend payout %16.824.1 69.9%   
Avg Mkt Cap Rs m23,07313,969 165.2%   
No. of employees `0005.71.6 358.4%   
Total wages/salary Rs m2,5581,487 172.1%   
Avg. sales/employee Rs Th2,352.56,631.9 35.5%   
Avg. wages/employee Rs Th450.9939.2 48.0%   
Avg. net profit/employee Rs Th190.4479.4 39.7%   
INCOME DATA
Net Sales Rs m13,34610,498 127.1%  
Other income Rs m192242 79.2%   
Total revenues Rs m13,53810,741 126.0%   
Gross profit Rs m1,6391,135 144.4%  
Depreciation Rs m390276 141.6%   
Interest Rs m290-   
Profit before tax Rs m1,4121,102 128.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293343 85.3%   
Profit after tax Rs m1,080759 142.4%  
Gross profit margin %12.310.8 113.6%  
Effective tax rate %20.731.1 66.5%   
Net profit margin %8.17.2 112.0%  
BALANCE SHEET DATA
Current assets Rs m5,9796,410 93.3%   
Current liabilities Rs m2,4328,828 27.5%   
Net working cap to sales %26.6-23.0 -115.4%  
Current ratio x2.50.7 338.7%  
Inventory Days Days6358 109.3%  
Debtors Days Days6038 157.3%  
Net fixed assets Rs m6,4031,406 455.2%   
Share capital Rs m182166 109.5%   
"Free" reserves Rs m9,2936,286 147.8%   
Net worth Rs m9,5486,455 147.9%   
Long term debt Rs m2300-   
Total assets Rs m12,8438,828 145.5%  
Interest coverage x50.0NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.01.2 87.4%   
Return on assets %8.68.6 100.5%  
Return on equity %11.311.8 96.2%  
Return on capital %14.317.1 84.0%  
Exports to sales %29.28.3 352.8%   
Imports to sales %6.321.0 30.1%   
Exports (fob) Rs m3,900869 448.5%   
Imports (cif) Rs m8472,209 38.3%   
Fx inflow Rs m4,356959 454.4%   
Fx outflow Rs m1,1622,612 44.5%   
Net fx Rs m3,194-1,653 -193.2%   
CASH FLOW
From Operations Rs m1,1191,070 104.5%  
From Investments Rs m-853-750 113.8%  
From Financial Activity Rs m-334-150 223.1%  
Net Cashflow Rs m-68171 -40.0%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 15.1 18.2 83.0%  
FIIs % 3.0 1.0 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 29.1 108.9%  
Shareholders   20,176 28,591 70.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 19, 2018 12:23 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS